Hedge Fund - Wildcat Capital Management
Allogene Therapeutics Inc. (ALLO)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $6,165,726 | 2.13% | 1,920,787 | $2.84 |
| 2 | 2023 - Q3 (2023-09-30) | $6,088,895 | 2.44% | 1,920,787 | $4.38 |
| 3 | 2023 - Q2 (2023-06-30) | $9,546,311 | 3.63% | 1,920,787 | $5.41 |
| 4 | 2023 - Q1 (2023-03-31) | $9,488,688 | 3.52% | 1,920,787 | $6.41 |
| 5 | 2022 - Q4 (2022-12-31) | $13,387,447 | 5.11% | 2,128,370 | $9.26 |
| 6 | 2022 - Q3 (2022-09-30) | $22,986,000 | 8.83% | 2,128,370 | $13.59 |
| 7 | 2022 - Q2 (2022-06-30) | $24,263,000 | 8.03% | 2,128,370 | $8.88 |
| 8 | 2022 - Q1 (2022-03-31) | $19,389,000 | 4.96% | 2,128,370 | $10.42 |
| 9 | 2021 - Q4 (2021-12-31) | $25,608,000 | 4.17% | 1,716,370 | $17.64 |
| 10 | 2021 - Q3 (2021-09-30) | $44,111,000 | 5.71% | 1,716,370 | $23.74 |
| 11 | 2021 - Q2 (2021-06-30) | $44,763,000 | 5.07% | 1,716,370 | $28.52 |
| 12 | 2021 - Q1 (2021-03-31) | $53,498,000 | 6.53% | 1,515,524 | $33.73 |
| 13 | 2020 - Q4 (2020-12-31) | $38,252,000 | 4.8% | 1,515,524 | $32.59 |
| 14 | 2020 - Q3 (2020-09-30) | $57,150,000 | 18.26% | 1,515,524 | $37.70 |
| 15 | 2020 - Q2 (2020-06-30) | $64,895,000 | 22.41% | 1,515,524 | $36.17 |
| 16 | 2020 - Q1 (2020-03-31) | $26,237,000 | 11.94% | 1,349,642 | $23.82 |
| 17 | 2019 - Q4 (2019-12-31) | $31,223,000 | 9% | 1,201,826 | $27.54 |
| 18 | 2019 - Q3 (2019-09-30) | $24,698,000 | 10.49% | 906,194 | $28.48 |
| 19 | 2019 - Q2 (2019-06-30) | $14,289,000 | 6.18% | 532,166 | $27.86 |
The displayed share prices are average quarterly stock market prices.